1. Home
  2. ELAN

as 12-18-2024 10:36am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Founded: 1954 Country:
United States
United States
Employees: N/A City: GREENFIELD
Market Cap: 6.3B IPO Year: 2018
Target Price: $16.75 AVG Volume (30 days): 4.5M
Analyst Decision: Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.41 EPS Growth: N/A
52 Week Low/High: $11.40 - $18.80 Next Earning Date: 11-07-2024
Revenue: $4,454,000,000 Revenue Growth: 1.99%
Revenue Growth (this year): 2.24% Revenue Growth (next year): 2.88%

ELAN Daily Stock ML Predictions

Share on Social Networks: